Back to results
US 2017/0290836 A1Published application
Arylquinazolines
AssigneeMerck Patent GmbH
InventorsThomas Fuchss, Ulrich Emde, Hans-Peter Buchstaller, Werner Mederski
Life of this patent
Estimating the term…
Abstract
The invention relates to novel compounds of the formula (I) which can be used for the inhibition of serine-threonine protein kinases and for the sensitisation of cancer cells to anticancer agents and/or ionising radiation.
Claims20
A compound of formula (I)
- in which
- X is CH, CF, S or N,
- Y is CH, S or N,
- Z is C or N,
- ---- forms, if Z=C, a double bond together with the single bond,
- is absent if Z=N,
- n is 1 or 2, where
- if n=1, X=S, and if n=2, both X=CH, or the X linked to the pyrimidine ring is CF and the X not linked to the pyrimidine ring is CH, or one X is CH and the other X is N;
- m is 1 or 2, where
- if m=1, Y=S, and if m=2, both Y=CH, or one Y is CH and the other Y is N;
- R1, R2, R3, R4, independently of one another, are H, Hal, CN, OH, CONH2, CONH(LA) or LA;
- R5 is H, Hal, CN or C≡CH;
- Cyc is phenyl, which may be unsubstituted or mono- or disubstituted, independently of one another, by R6, or is Het1;
- Het1 is a mono- or bicyclic, 5-10-membered heterocycle, having 1-3 N, O or S atoms, or 1-4 N atoms, which may be unsubstituted or mono-, di- or trisubstituted, independently of one another, by R6, or may be monosubstituted by Het2;
- R6 is Hal, LA, oxo, CN, or NH2;
- LA is unbranched or branched alkyl having 1-5 C atoms, which may be saturated or partially unsaturated, in which 1-3H atoms may be replaced by Hal, or one H atom may be replaced by CN or Het2, or one or two CH2 groups may be replaced by O, NH, N(CH3) or CO;
- Het2 is a 3-5-membered aliphatic homo- or heterocycle having 0, 1, 2 or 3 N, O or S atoms, which is unsubstituted;
- and
- Hal is F, Cl, Br or I;
- or a physiologically acceptable salt, tautomer or stereoisomer thereof, including mixtures thereof in all ratios.
17 more elements
A compound of formula (II)
- in which
- X is CH, CF, S or N,
- Y is CH, S or N,
- Z is C or N,
- n is 1 or 2, where
- if n=1, X=S, and if n=2, both X=CH, or the X linked to the pyrimidine ring is CF and the X not linked to the pyrimidine ring is CH, or one X is CH and the other X is N;
- m is 1 or 2, where
- if m=1, Y=S, and if m=2, both Y=CH, or one Y is CH and the other Y is N;
- R1 and R2 independently of one another, are H, Hal, CN, OH, CONH2, CONH(LA) or LA;
- R3 is Hal, CN, OH, CONH2, CONH(LA) or LA;
- R5 is H, Hal, CN or C≡CH,
- LA is unbranched or branched alkyl having 1-5 C atoms, which may be saturated or partially unsaturated, in which 1-3H atoms may be replaced by Hal, or one H atom may be replaced by CN or Het2, or one or two CH2 groups may be replaced by O, NH, N(CH3) or CO;
- Hal is F, Cl, Br or I;
- Cyc is Het1;
- Het1 is a mono- or bicyclic, 5-10-membered heterocycle, having 1-3 N, O or S atoms, or 1-4 N atoms, which may be monosubstituted by Het2;
- Het2 is a 3-5-membered aliphatic homo- or heterocycle having 0, 1, 2 or 3 N, O or S atoms, which is unsubstituted;
- R6′, R6″, independently of one another, are H, Hal, LA, oxo, CN, NH2 or Het2;
- Q1, Q2, independently of one another, are CH, N or NH and are in each case unsubstituted;
- and
- ---- denotes the presence or absence of double bonds in Cyc;
- or a physiologically acceptable salt, tautomer or stereoisomer thereof, including mixtures thereof in all ratios.
18 more elements
(canceled)
A compound of formula (IIa)
- in which
- Y is CH, S or N,
- R1 is H, Hal, CN, OH, CONH2, CONH(LA) or LA;
- LA is unbranched or branched alkyl having 1-5 C atoms, which may be saturated or partially unsaturated, in which 1-3H atoms may be replaced by Hal, or one H atom may be replaced by CN or Het2, or one or two CH2 groups may be replaced by O, NH, N(CH3) or CO;
- Hal is F, Cl, Br or I;
- R2, R3, independently of one another, are Hal, CN, OH, CONH2, CON(LA) or LA;
- R5 is H, Hal, CN or C≡CH,
- Cyc is Het1;
- Het1 is a mono- or bicyclic, 5-10-membered heterocycle, having 1-3 N, O or S atoms, or 1-4 N atoms, which may be monosubstituted by Het2;
- Het2 is a 3-5-membered aliphatic homo- or heterocycle having 0, 1, 2 or 3 N, O or S atoms, which is unsubstituted;
- R6′, R6″, independently of one another, are H, Hal, LA, oxo, CN, NH2 or Het2;
- Q1, Q2, independently of one another, are CH, N or NH and are in each case unsubstituted;
- X1 is CH, CF or N;
- X2 is CH or N,
- where X1, X2 are not simultaneously N;
- Y is CH or N;
- and
- ---- denotes the presence or absence of double bonds in Cyc;
- or a physiologically acceptable salt, tautomer or stereoisomer thereof, including mixtures thereof in all ratios.
16 more elements
(canceled)
(canceled)
(canceled)
(canceled)
-17. (canceled)
A compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.